AdaptHealth Stock Plummets 47% After Huge Earnings Miss and Guidance Cut

Earnings Impact 4
โดย The Motley Fool·US·Read original
Summary · why it matters

AdaptHealth stock fell 47% this week after the company reported second-quarter results that missed expectations and slashed its full-year guidance. The company posted a loss of $1.07 per share, far below the average analyst estimate of a $0.15 profit, while revenue of $740.3 million came in roughly $106.5 million below forecasts. AdaptHealth now expects full-year sales between $2.85 billion and $2.89 billion, down from its prior range of $3.45 billion to $3.52 billion, largely due to discontinuing its Diabetes Health business and shifting guidance to continuing operations only. Adjusted EBITDA guidance was cut to $490 million to $520 million from $680 million to $730 million, and free cash flow is now seen at $80 million to $120 million, down from $175 million to $225 million.

Impact on stocks 1

Aging Population▼ · 1 stocks
© 2026 MarketDXNews